World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
83
Citations
33486
World Ranking
1416
National Ranking
722

Mark Boguniewicz publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Mark Boguniewicz sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 349 publications — 74th percentile

74% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Mark Boguniewicz D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Mark Boguniewicz sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 83 D-Index — 71st percentile

71% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Mark Boguniewicz is affiliated with National Jewish Health in the United States and has an extensive research portfolio in the field of medicine, with a particular focus on dermatology and immunology.

Their work primarily spans several subfields of study, including:

  • Dermatology
  • Immunology and Allergy
  • Physiology
  • Rheumatology
  • Immunology

The main topics covered in their research include:

  • Dermatology and Skin Diseases
  • Allergic Rhinitis and Sensitization
  • Asthma and Respiratory Diseases
  • Food Allergy and Anaphylaxis Research
  • Urticaria and Related Conditions
  • IL-33, ST2, and ILC Pathways
  • Transgenic Plants and Applications

Frequent publication venues for Boguniewicz's work are:

  • Journal of Allergy and Clinical Immunology
  • Annals of Allergy Asthma & Immunology
  • British Journal of Dermatology
  • Journal of the American Academy of Dermatology
  • The Journal of Allergy and Clinical Immunology In Practice

Among the recent papers associated with Boguniewicz are:

  • Efficacy and safety of dupilumab with concomitant topical corticosteroids in children 6 to 11 years old with severe atopic dermatitis: A randomized, double-blinded, placebo-controlled phase 3 trial (2020) - Journal of the American Academy of Dermatology
  • Atopic dermatitis (eczema) guidelines: 2023 American Academy of Allergy, Asthma and Immunology/American College of Allergy, Asthma and Immunology Joint Task Force on Practice Parameters GRADE- and Institute of Medicine-based recommendations (2023) - Annals of Allergy Asthma & Immunology
  • The infectious complications of atopic dermatitis (2020) - Annals of Allergy Asthma & Immunology
  • Systemic treatments for atopic dermatitis (eczema): Systematic review and network meta-analysis of randomized trials (2023) - Journal of Allergy and Clinical Immunology
  • Dupilumab significantly improves skin barrier function in patients with moderate-to-severe atopic dermatitis (2022) - Allergy

Frequent co-authors collaborating with Boguniewicz include:

  • Jonathan I. Silverberg
  • Eric L. Simpson
  • Peck Y. Ong
  • Anna De Benedetto
  • Lisa A. Beck

Best Publications

  • Endogenous Antimicrobial Peptides and Skin Infections in Atopic Dermatitis

    Peck Y. Ong;Takaaki Ohtake;Corinne Brandt;Ian Strickland

  • New insights into atopic dermatitis

    Donald Y.M. Leung;Mark Boguniewicz;Michael D. Howell;Ichiro Nomura

  • Atopic Dermatitis: A Disease of Altered Skin Barrier and Immune Dysregulation

    Mark Boguniewicz;Donald Y. M. Leung

  • Cytokine modulation of atopic dermatitis filaggrin skin expression

    Michael D. Howell;Byung Eui Kim;Peisong Gao;Audrey V. Grant

  • Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis.

    Qutayba Hamid;Mark Boguniewicz;Donald Y. M. Leung

  • Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report

    C A Akdis;M Akdis;T Bieber;C Bindslev-Jensen

  • Cytokine Milieu of Atopic Dermatitis, as Compared to Psoriasis, Skin Prevents Induction of Innate Immune Response Genes

    Ichiro Nomura;Elena Goleva;Michael D. Howell;Quatyba A. Hamid

  • Tight junction defects in patients with atopic dermatitis.

    Anna De Benedetto;Nicholas M. Rafaels;Laura Y. McGirt;Andrei I. Ivanov

  • Loricrin and Involucrin Expression is Down-Regulated by Th2 Cytokines through STAT-6

    B.E. Kim;D.Y.M. Leung;M. Boguniewicz;M.D. Howell

  • Efficacy and safety of crisaborole ointment, a novel, nonsteroidal phosphodiesterase 4 (PDE4) inhibitor for the topical treatment of atopic dermatitis (AD) in children and adults

    Amy S. Paller;Wynnis L. Tom;Wynnis L. Tom;Mark G. Lebwohl;Robin L. Blumenthal

  • Patient burden and quality of life in atopic dermatitis in US adults: A population-based cross-sectional study

    Jonathan I. Silverberg;Joel M. Gelfand;David J. Margolis;Mark Boguniewicz

  • In vivo expression of IL-12 and IL-13 in atopic dermatitis

    Qutayba Hamid;Tanveer Naseer;Eleanor M. Minshall;Yan L. Song

  • IL-31 is associated with cutaneous lymphocyte antigen-positive skin homing T cells in patients with atopic dermatitis.

    Janine Bilsborough;Donald Y.M. Leung;Mark Maurer;Michael Howell

  • Atopic dermatitis: A practice parameter update 2012

    Lynda Schneider;Stephen Tilles;Peter Lio;Mark Boguniewicz

  • Efficacy and Safety of Dupilumab in Adolescents With Uncontrolled Moderate to Severe Atopic Dermatitis: A Phase 3 Randomized Clinical Trial.

    Eric L. Simpson;Amy S. Paller;Elaine C. Siegfried;Mark Boguniewicz

  • Safety and efficacy of pimecrolimus (ASM 981) cream 1% in the treatment of mild and moderate atopic dermatitis in children and adolescents.

    Lawrence F. Eichenfield;Anne W. Lucky;Mark Boguniewiczc;Richard G.B. Langley

  • Cytokine Milieu of Atopic Dermatitis Skin Subverts the Innate Immune Response to Vaccinia Virus

    Michael D. Howell;Richard L. Gallo;Mark Boguniewicz;James F. Jones

  • Recent insights into atopic dermatitis and implications for management of infectious complications.

    Mark Boguniewicz;Donald Y.M. Leung

  • Polarized in vivo expression of IL-11 and IL-17 between acute and chronic skin lesions

    Masao Toda;Donald Y.M. Leung;Sophie Molet;Mark Boguniewicz

  • A randomized, vehicle-controlled trial of tacrolimus ointment for treatment of atopic dermatitis in children

    Mark Boguniewicz;Virginia C. Fiedler;Sharon Raimer;Ira D. Lawrence

  • Cytokine modulation of atopic dermatitis filaggrin skin expression.

    Unknown

Frequent Co-Authors

Donald Y.M. Leung
Donald Y.M. Leung National Jewish Health
Eric L. Simpson
Eric L. Simpson Oregon Health & Science University
Lisa A. Beck
Lisa A. Beck University of Rochester Medical Center
Lynda C. Schneider
Lynda C. Schneider Boston Children's Hospital
Jon M. Hanifin
Jon M. Hanifin Oregon Health & Science University
Jonathan I. Silverberg
Jonathan I. Silverberg George Washington University Hospital
David J. Margolis
David J. Margolis University of Pennsylvania
Lawrence F. Eichenfield
Lawrence F. Eichenfield University of California, San Diego
Joel M. Gelfand
Joel M. Gelfand University of Pennsylvania
Amy S. Paller
Amy S. Paller Northwestern University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring allied healthcare fields can broaden career opportunities. Nursing, for example, offers a solid foundation in patient care and biomedical sciences, which complements immunology knowledge well. Many start with accelerated programs designed for career changers or non-nurses, such as online BSN programs for non nurses.

If you're looking for accessible entry points into nursing, some of the easiest ABSN programs to get into offer flexible formats and streamlined admissions. These programs help fast-track your education and can be a stepping stone toward advanced practice.

Licensed Practical Nurse (LPN) programs also present options for quicker entry into healthcare. Identifying which LPN programs are easiest to get into allows students to find programs that fit their schedule and get practical experience in patient care.

For those pursuing higher levels of specialization, nurse practitioner degrees provide advanced clinical skills and leadership opportunities. Exploring the easiest nurse practitioner program options can guide you to programs that balance quality education with accessible entry requirements.

Best Scientists Citing Mark Boguniewicz

Trending Scientists

Recently Published Articles